ArticleCurrent oncology (Toronto, Ont.)2024

Durable Response to Atezolizumab in Extensive-Stage Small-Cell Lung Cancer Leading to 60 Months Overall Survival: A Case Report.

Freeman Paczkowski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.